Table 5.
Effect of matrine combined with anticancer drugs on cell inhibitory ratio in A549 cells (%). Data are presented as mean ± SEM. The values having different superscript letters were significantly different with other groups (P < 0.05; n = 6).
Item | 0 μM Matrine | 10 μM Matrine | 50 μM Matrine | 100 μM Matrine |
---|---|---|---|---|
Cisplatin mM | ||||
0.1 | 9.3 ± 3.4b | 13.5 ± 4.2b | 19.1 ± 4.8ab | 24.8 ± 5.1a |
1.0 | 21.7 ±3.7b | 29.5 ± 3.1b | 39.3 ± 4.5a | 48.2 ± 6.1a |
5.0 | 36.2 ± 4.2b | 44.7 ± 5.9b | 57.2 ± 3.1a | 70.7 ± 6.3a |
5-Fluorouracil mM | ||||
0.1 | 6.4 ± 1.3b | 9.7 ± 2.7b | 15.6 ± 3.7ab | 21.3 ± 3.2a |
1.0 | 17.9 ± 2.9b | 24.5 ± 3.1a | 33.3 ± 3.7a | 42.1 ± 4.8a |
10.0 | 28.4 ± 3.9b | 34.8 ± 5.9b | 49.7 ± 5.0a | 64.3 ± 6.8a |
Paclitaxel mM | ||||
0.1 | 8.7 ± 1.9b | 15.3 ± 3.7a | 24.8 ± 2.8a | 29.1 ± 4.9a |
1.0 | 19.4 ± 2.3c | 27.3 ± 3.4bc | 37.8 ± 4.3b | 47.5 ± 4.5a |
5.0 | 33.2 ± 5.3b | 47.9 ± 5.9a | 60.1 ± 5.7a | 75.3 ± 5.1a |